Back to Search
Start Over
Epigallocatechin-3-Gallate Provides Protection Against Alzheimer’s Disease-Induced Learning and Memory Impairments in Rats
- Source :
- Drug Design, Development and Therapy
- Publication Year :
- 2021
- Publisher :
- Dove Press, 2021.
-
Abstract
- Shanji Nan, Peng Wang, Yizhi Zhang, Jia Fan Department of Neurology, The Second Hospital of Jilin University, Changchun, 130041, People’s Republic of ChinaCorrespondence: Jia FanDepartment of Neurology, The Second Hospital of Jilin University, No. 218, Ziqiang Street, Changchun, 130041, Jilin Province, People’s Republic of ChinaTel +86-13843028656Email fanjia@jlu.edu.cnPurpose: Recent evidence has highlighted the anti-inflammatory properties of the constituent of Green Tea Polyphenols (GTP), epigallocatechin-3-gallate (EGCG) which has been suggested to exert a neuroprotective effect on Alzheimer’s disease (AD). The current study aimed to elucidate the effect of EGCG on memory function in rats with AD.Methods: AD rat models were initially established through an injection with Aβ 25– 35 solution, followed by gavage with EGCG at varying doses to determine the effect of EGCG on learning and cognitive deficits in AD. Morris water maze test was conducted to evaluate the spatial memory function of the rats. Immunohistochemistry and Western blot analysis were performed to identify Tau phosphorylation. The expression of β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) mRNA and protein in rat hippocampus was measured by reverse transcription quantitative polymerase chain reaction (RT-qPCR) and Western blot analysis. Acetylcholinesterase (AchE) activity, Aβ 1-42 expression and Ach content were all detected using enzyme-linked immunosorbent assay (ELISA).Results: EGCG intervention brought about a decrease in the escape latency period while increasing the time at the target quadrant among the AD rats. EGCG decreased the hyperphosphorylation of Tau in hippocampus. BACE1 expression and activity as well as the expression of Aβ 1-42 were suppressed by EGCG. Moreover, EGCG promoted Ach content by diminishing the activity of AchE.Conclusion: The current study demonstrates that EGCG may diminish the hyperphosphorylation of the Tau protein, downregulate BACE1 and Aβ 1-42 expression to improve the antioxidant system and learning and memory function of rats with AD.Keywords: Aβ 1-42, ACh, AChE, BACE1, epigallocatechin-3-gallate, learning and memory function, tau hyperphosphorylation
- Subjects :
- Male
0301 basic medicine
Pharmaceutical Science
Morris water navigation task
Hippocampus
tau hyperphosphorylation
Pharmacology
Antioxidants
Catechin
Rats, Sprague-Dawley
chemistry.chemical_compound
0302 clinical medicine
Drug Discovery
Aspartic Acid Endopeptidases
Spatial Memory
Original Research
biology
medicine.diagnostic_test
food and beverages
BACE1
Acetylcholinesterase
Neuroprotective Agents
Real-time polymerase chain reaction
030220 oncology & carcinogenesis
epigallocatechin-3-gallate
Tau protein
Hyperphosphorylation
tau Proteins
complex mixtures
Neuroprotection
03 medical and health sciences
Western blot
Alzheimer Disease
medicine
Animals
Aβ1-42
Maze Learning
Memory Disorders
Amyloid beta-Peptides
Drug Design, Development and Therapy
Dose-Response Relationship, Drug
learning and memory function
Peptide Fragments
Rats
030104 developmental biology
chemistry
biology.protein
AChE
ACh
sense organs
Amyloid Precursor Protein Secretases
Cognition Disorders
Subjects
Details
- Language :
- English
- ISSN :
- 11778881 and 13843028
- Database :
- OpenAIRE
- Journal :
- Drug Design, Development and Therapy
- Accession number :
- edsair.doi.dedup.....f95cab9a2679289411902f9a0a9ba0ca